以上内容来自Benzinga Earnings专栏,原文如下:
Novo Nordisk (NYSE:NVO) reported quarterly earnings of DKK6.34 per share which beat the analyst consensus estimate of DKK 5.82 by 8.93 percent. This is a 29.12 percent increase over earnings of DKK 4.91 per share from the same period last year. The company reported quarterly sales of DKK 85.683 billion which beat the analyst consensus estimate of DKK 79.730 billion by 7.47 percent. This is a 30.09 percent increase over sales of DKK 65.863 billion the same period last year.